Miguel Ángel López Zúñiga

ORCID: 0000-0002-2583-316X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Hepatitis C virus research
  • Lipoproteins and Cardiovascular Health
  • Ultrasound in Clinical Applications
  • HIV Research and Treatment
  • Liver Disease Diagnosis and Treatment
  • HIV/AIDS Research and Interventions
  • Otolaryngology and Infectious Diseases
  • Cervical Cancer and HPV Research
  • Infectious Diseases and Tuberculosis
  • Health Systems, Economic Evaluations, Quality of Life
  • Colorectal and Anal Carcinomas
  • HIV/AIDS drug development and treatment
  • Ophthalmology and Eye Disorders
  • Cardiac Imaging and Diagnostics
  • Radiology practices and education
  • Infective Endocarditis Diagnosis and Management
  • Facial Trauma and Fracture Management
  • COVID-19 and healthcare impacts
  • Pleural and Pulmonary Diseases
  • Pneumothorax, Barotrauma, Emphysema
  • Endometrial and Cervical Cancer Treatments
  • Phonocardiography and Auscultation Techniques
  • Inflammatory Myopathies and Dermatomyositis

Hospital Universitario Virgen de las Nieves
2020-2023

Complejo Hospitalario de Jaén
2016-2022

Universidad de Jaén
2021

Complejo Hospitalario Torrecárdenas
2020

Complejo Hospitalario Universitario de Santiago
2020

Sociedad Española de Medicina Interna
2017

Complejo Hospitalario Universitario de Granada
2016

Instituto de Investigación Biosanitaria de Granada
2016

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013

Valparaiso University
2009

Objective Test whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone or dexamethasone is associated increased survival in COVID-19 patients at risk of hyper-inflammatory response. Provide some initial diagnostic criteria using laboratory markers to stratify these patients. Methods This a prospective observational study, 318 met the inclusion criteria. 64 (20.1%) were treated HDCPT by least 1.5mg/kg/24h equivalent. A multivariate Cox regression (controlling for...

10.1371/journal.pone.0243964 article EN cc-by PLoS ONE 2021-01-28
Ignacio Zapardiel Sara Iacoponi Pluvio Coronado Kamil Zalewski Frank Chen and 91 more Christina Fotopoulou Polat Dursun Ioannis Kotsopoulos Robert Jach Alessandro Buda María José Martínez‐Serrano Christoph Grimm Robert Fruscio Enrique García García Jacek Jan Sznurkowski C Ruiz M Noya Dib Barazi Javier Dı́ez Begoña Díaz de la Noval Arnoldas Bartusevičius Pierandrea De Iaco María Calado Otero M. Berdeal Díaz Dimitrios Haidopoulos Sílvia Franco Paweł Blecharz Miguel Ángel López Zúñiga Patricia Rubio Bárbara Gardella Dimitrios Papatheodorou Yusuf Yıldırım Francesc Fargas Ronalds Mačuks M. Arones Meritxell Arqué M. T. Bernal Marcello Ceccaroni L. Covo-Pinto Ignacio Cristóbal José Luis Velasco Cruz Javier de la Torre H. DiFiore Ahmet Doğan Inge Etxabe L Feijoo Alberto Fernández Laura Morales‐Fernández M. Fernandez Anna Festi C. Garcia-Casals R. A. Garrido Blanca Gil‐Ibáñez Antonio Gil‐Moreno Àngels Ginès A. I. Gomez Ivan G. Gomez E Gonçalves Luís Fernández González Núria Grané C Grigoriadis Leandro Gutiérrez N. Herraiz E. Irslinger Ahmet Cem İyibozkurt Laura Joigneau Helén Karlsson A Kondi-Pafiti Marcin Mardas M. Marino Antonio Martı́nez Cristina Martínez M. Martos S. Menjón V Mitsopoulos Pablo A. Mora S. Morales Antonio Moreno A. Nieto André Novo Martin K. Oehler Itxaro Pérez Jurgen M.J. Piek Stephan Polterauer Ángel De Prado M. C. Reula María José Robles Margarita Romeo Consolación Rosado Jakub Rzepka Ramón García‐Sánz Jalid Sehouli Carolina Soler‐Botija Vladyslav Sukhin Dimitrios Tsolakidis Pedro Vieira‐Baptista

<h3>Objective</h3> This study aimed to analyze the prognostic factors for overall and progression-free survival in patients with vulvar cancer. <h3>Methods</h3> international, multicenter, retrospective included 2453 diagnosed cancer at 100 different institutions. Inclusion criteria were institutional review board approval from each collaborating center, pathologic diagnosis of invasive carcinoma vulva, primary treatment performed participating center. Patients intraepithelial neoplasia or...

10.1136/ijgc-2019-000526 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2020-06-23

El departamento del Chocó ubicado en la zona pacifica territorio colombiano, goza de una importante biodiversidad endémica flora y fauna presente su extensa región selvática (Arellano-P, 2020), además gozar con amplia diversidad destacada productos sector agropecuario, ya que, por sus pisos térmicos también variados, cuenta nutrida gama vegetales como hortalizas, legumbres, tubérculos, frutales, plantas forrajeras alto contenido nutricional, especies pecuarias; entre otros, que permiten...

10.56712/latam.v6i1.3399 article ES cc-by LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades 2025-02-03

Background: In general, transthoracic echocardiography (TTE) is the first diagnostic test used for patients with bacteremia or candidemia and clinical signs of Infective Endocarditis (IE). Point-of-care ultrasound (POCUS) may be in addition to physical examination detection structural heart disease valve abnormalities. Objective: To determine accuracy POCUS suggestive IE, including vegetation, valvular regurgitation, disease, hepatomegaly, splenomegaly septic embolisms, candidemia. Design:...

10.3390/jcm11133636 article EN Journal of Clinical Medicine 2022-06-23

Patients with human immunodeficiency virus type 1 (HIV-1) who receive antiretroviral therapy (ART) often achieve increased survival and improved quality of life. In this respect, monotherapy darunavir/ritonavir (mDRV/r) can be a useful treatment strategy. This prospective study analyses the effect mDRV/r on sperm viral load in group 28 patients had previously been given conventional ART recorded <20 copies/mL for at least six months. These were dose 800/100 mg 48 weeks. At baseline (V0),...

10.1371/journal.pone.0159305 article EN cc-by PLoS ONE 2016-07-21

Many patients previously using darunavir/ritonavir (DRV/r) (800/100mg) have switched to darunavir/cobicistat (DRV/C) (800/150 mg) either as part of triple therapy (ART) or monotherapy with DRV (mDRV). The latter approach continues be used in some countries for receiving long-term treatment. However, date, the behaviour DRV/C seminal compartment has not been analysed. This study explores how combination behaves monotherapy, respect control viral load and quality. To this end, we studied 20...

10.1371/journal.pone.0196257 article EN cc-by PLoS ONE 2018-04-24

Objective To provide insight on viral kinetics and genetic diversity of HIV in seminal plasma at baseline 1 month after initiating antiretroviral therapy (ART). Patients methods Blood samples from patients with newly diagnosed were obtained before ART initiation (T0) (T1). env was studied using deep sequencing Nextera V3 chemistry a MiSeq Illumina platform. The number quasispecies (5% cut-off) Shannon Index used to analyse diversity. Results Forty-seven ART-naive recruited between September...

10.1136/sextrans-2020-054439 article EN cc-by-nc Sexually Transmitted Infections 2020-04-03

10.1016/j.medcle.2020.04.009 article EN Medicina Clínica (English Edition) 2020-07-02

Since the onset of COVID-19 pandemic in December 2019, many drugs have been proposed and used an attempt to address this new disease, which has led constant changes updates treatment guidelines their recommendations. This review sets out what evolution like throughout pandemic. To end, a literature available on Pubmed, MedRxiv WHO, NIH NICE guides was carried out. Based information it seen that all drugs, only corticosteroids, Remdesivir Tocilizumab shown some benefit studies patients with...

10.15568/am.2023.817.rev02 article EN ACTUALIDAD MEDICA 2023-01-01
Coming Soon ...